Skip to main content

Institutional intelligence for METROPOLIS HEALTHCARE LTD.

Cross-view mutual fund activity and super-investor shareholding · Jun 2026 SHP.

Ownership breakdown

Category totals from the official quarterly Shareholding Pattern filing (Jun 2026). Sums to 100.00%.

  • Promoters48.86%
  • FII11.03%
  • Mutual Funds32.67%
  • DII (ex-MF)2.45%
  • Retail & others4.99%
  • 1% Club 15.03%(subset)

Super Investors and 1% Club names below are disclosed holders at or above 1%. They are subsets of the categories above, not additive. View filing

Holder details (≥1% disclosed names)

Promoters

Promoter & promoter group

48.86%3 named
HolderStakeSharesValue (₹ Cr)
30.27%6,27,64,864₹3.40k Cr
11.05%2,29,18,740₹1.24k Cr
7.19%1,49,00,980₹807.0 Cr

Mutual Funds

Domestic mutual funds & UTI

32.67%3 named
HolderStakeSharesValue (₹ Cr)
9.66%2,00,32,992₹1.08k Cr
3.72%77,04,001₹417.3 Cr
1.45%30,11,297₹163.1 Cr

1% Club — Individuals & others

Non-promoter ≥1% holders not matched to a curated profile

15.03%5 named
HolderStakeSharesValue (₹ Cr)
4.24%87,88,038₹476.0 Cr
3.79%78,52,272₹425.3 Cr
2.84%58,95,396₹319.3 Cr
2.21%45,81,344₹248.1 Cr
1.95%40,48,722₹219.3 Cr

FII / FPI

Foreign portfolio investors

11.03%No names

No named holders ≥1% in this bucket.

Retail & others

Holders below 1% disclosure threshold and public non-institutions

4.99%

SEBI requires naming only shareholders with ≥1% stake. The remaining 4.99% includes retail investors, small HNIs, employee trusts, and other holders below the disclosure threshold — aggregated in the official filing.

DII (other)

Insurance, banks, AIF, other domestic institutions

2.45%No names

No named holders ≥1% in this bucket.

Super Investors

Curated tracked investor profiles

No names

No curated super investor holds ≥1% in the latest filing. See FII, DII, and mutual fund holders in the sections above.

Shareholding data sourced from NSE/BSE regulatory filings. Category chart uses official filing totals; named holder lists include every disclosed ≥1% position. Not investment advice. See our disclaimer and methodology.